Monopar Therapeutics MNPR
NASDAQ MNPR
$77.97 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Selling, General & Administrative (2017 - 2026)

Updated

Monopar Therapeutics (MNPR) posted Selling, General & Administrative of $1.88 million for Q2 2026, up 24.8% from $1.5 million a year earlier.

Analysis

Monopar Therapeutics (MNPR) Selling, General & Administrative (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Monopar Therapeutics was $6.46 million, up 49.2% year-over-year; for FY2023, it was $3.23 million, up 9.7% from FY2022.

  • Annual Selling, General & Administrative has increased for seven consecutive years, with a five-year compound annual growth rate of 15.7% (FY2018 to FY2023).
  • In prior years, Monopar Therapeutics' Selling, General & Administrative was $2.95 million in FY2022 (+11.8%), $2.63 million in FY2021 (+7.8%), $2.44 million in FY2020 (+3.8%) and $2.36 million in FY2019 (+51.3%).
  • The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q1 2017.
  • On a year-over-year basis, Selling, General & Administrative increased in four of the last five quarters, with growth averaging 79.1%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2025, with growth of 154.5%; the weakest was Q3 2024, with a decline of 21.2%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Monopar Therapeutics 666.05 Mn 384.28 Mn - 1.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.88 Mn
Sep 30, 2025 1.50 Mn
Jun 30, 2025 1.50 Mn
Mar 31, 2025 1.58 Mn
Sep 30, 2024 590,624.00
Jun 30, 2024 657,806.00
Mar 31, 2024 757,281.00
Dec 31, 2023 876,397.00
Sep 30, 2023 749,474.00
Jun 30, 2023 733,496.00
Mar 31, 2023 871,675.00
Dec 31, 2022 806,030.00
Sep 30, 2022 675,115.00
Jun 30, 2022 684,877.00
Mar 31, 2022 779,254.00
Dec 31, 2021 698,441.00
Sep 30, 2021 631,698.00
Jun 30, 2021 615,965.00
Mar 31, 2021 687,936.00
Dec 31, 2020 628,377.00
API Access

Monopar Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MNPR&period=max&api_key=YOUR_API_KEY